Livongo Health (Livongo Health) ROCE % : -7.21% (As of Sep. 2020)

View and export this data going back to 2019. Start your Free Trial

What is Livongo Health ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Livongo Health's annualized ROCE % for the quarter that ended in Sep. 2020 was -7.21%.

Livongo Health ROCE % Historical Data

The historical data trend for Livongo Health's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Livongo Health ROCE % Chart

Livongo Health Annual Data

Trend

Dec17

Dec18

Dec19

ROCE %

-24.52

-32.13

-17.65

Livongo Health Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20
ROCE %	Get a 7-Day Free Trial							-25.84	-6.36	-5.20	0.35	-7.21

Livongo Health ROCE % Calculation

Livongo Health's annualized ROCE % for the fiscal year that ended in Dec. 2019 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2019 )		(A: Dec. 2018 )		(A: Dec. 2019 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2019 )		(A: Dec. 2018 )		(A: Dec. 2019 )
	=	-59.538	/	( ( (180.253 - 24.436)	+	(560.561 - 41.875) )	/ 2 )
	=	-59.538	/	( (155.817	+	518.686)	/ 2 )
	=	-59.538	/	337.2515
	=	-17.65 %

Livongo Health's ROCE % of for the quarter that ended in Sep. 2020 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2020 )		(Q: Jun. 2020 )		(Q: Sep. 2020 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2020 )		(Q: Jun. 2020 )		(Q: Sep. 2020 )
	=	-71.552	/	( ( (1049.287 - 47.859)	+	(1043.962 - 61.148) )	/ 2 )
	=	-71.552	/	( ( 1001.428	+	982.814 )	/ 2 )
	=	-71.552	/	992.121
	=	-7.21 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2020) EBIT data.

Livongo Health (NAS:LVGO) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Livongo Health ROCE % Related Terms

Thank you for viewing the detailed overview of Livongo Health's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Livongo Health (Livongo Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Livongo Health Inc (NAS:LVGO) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

150 West Evelyn Avenue, Suite 150, Mountain View, CA, USA, 94041

Website

https://www.livongo.com

Livongo Health Inc provides a data science and technology enabled platform for detection of diabetes. Its additional solutions include Livongo for Hypertension, Livongo for Prediabetes and Weight Management, and Livongo for Behavioral Health by myStrength. The company's client comprise of employers, health plans, government entities, and labor unions. Its operations are primarily located in the United States.

Executives

Lee Shapiro	officer: Chief Financial Officer	C/O ALLSCRIPTS HEALTCHARE SOLUTIONS, 2401 COMMERCE DR, LIBERTYVILLE IL 60048
Glen Tullman	director, officer: Executive Chairman	C/O LIVONGO HEALTH, INC., 150 WEST EVELYN AVENUE, SUITE 150, MOUNTAIN VIEW CA 94041
Karen L Daniel	director	2801 80TH STREET, KENOSHA WI 53141
Philip E Green	director	C/O LIVONGO HEALTH, INC, 150 WEST EVELYN AVENUE, SUITE 150, MOUNTAIN VIEW CA 94041
Kenneth I Chenault	10 percent owner	C/O GENERAL CATALYST, 20 UNIVERSITY ROAD, 4TH FLOOR, CAMBRIDGE MA 02138
Gc Venture Lh Manager, Llc	10 percent owner	20 UNIVERSITY ROAD, 4TH FLOOR CAMBRIDGE MA 02138
Gc Partners Holdings, Lp	10 percent owner	20 UNIVERSITY ROAD, 4TH FLOOR, CAMBRIDGE MA 02138
Gcgm Investment Holdings, Lp	10 percent owner	20 UNIVERSITY ROAD, 4TH FLOOR, CAMBRIDGE MA 02138
General Catalyst Group Management Holdings Gp, Llc	10 percent owner	20 UNIVERSITY ROAD, 4TH FLOOR, CAMBRIDGE MA 02138
General Catalyst Group Management Holdings, L.p.	10 percent owner	20 UNIVERSITY ROAD, 4TH FLOOR, CAMBRIDGE MA 02138
General Catalyst Gp Vi, Llc	10 percent owner	20 UNIVERSITY ROAD, 4TH FLOOR, CAMBRIDGE MA 02138
General Catalyst Gp Viii, Llc	10 percent owner	20 UNIVERSITY ROAD, 4TH FLOOR, CAMBRIDGE MA 02138
General Catalyst Partners Vi, L.p.	10 percent owner	20 UNIVERSITY ROAD, 4TH FLOOR, CAMBRIDGE MA 02138
General Catalyst Group Viii Supplemental, L.p.	10 percent owner	20 UNIVERSITY ROAD, 4TH FLOOR, CAMBRIDGE MA 02138
General Catalyst Group Viii, L.p.	10 percent owner	20 UNIVERSITY ROAD, 4TH FLOOR, CAMBRIDGE MA 02138